• EMP Levo

    EMP Levo is the result of a successful partnership between Dutch-based PharmaMatch and Pharma-Data from Greece and has it’s principal office in Zurich, Switzerland.

    Read more

LevothyroxinePharmaMatch is a successful company in the European B-to-B generic pharmaceutical industry, focused on licensing of know how.

Pharma-Data has specialized for many years in the product development of pharmaceutical formulas in it’s dedicated R&D center in Athens, Greece.

Since its founding in 2007, EMP Levo has distinguished itself as a specialist in the international market for pharmaceutical products; generic-plus, added-value generics and niche formulations.

EMP Levo has since then successfully developed Levothyroxine Oral Solution. EMP Levo’s Levothyroxine Oral Solution is patent protected in EU and USA, while used by BP as reference product for the establishment of the relevant official monograph.

Levothyroxine OS has already been introduced in a number of countries and EMP is currently focusing on a global roll out.

innovation-award-2015EMP Levo was granted the award for the Innovation of the Year 2015 for its Levothyroxine Development at the Global Generics and Biosimilar Awards Ceremony held during the CPhI in Madrid.

© Copyright - EMP Levo